GENERAL ATLANTIC, L.P.
13F Reported Value
ⓘ$2.1B
Holdings
12
Latest Filing
2026-03-31
Filing Quarter
Q1 2026
Portfolio Overview
GENERAL ATLANTIC, L.P. disclosed 12 positions worth $2.1B in its Form 13F-HR for Q1 2026, led by $DLO (dLocal Ltd) at 28.2% of the equity portfolio, followed by $CHYM and $XP. During the quarter the fund opened 0 new positions and exited 1 and a full exit from $ALHC. The portfolio is most concentrated in Financials (36.8% of disclosed assets). All figures are sourced directly from GENERAL ATLANTIC, L.P.’s Form 13F-HR filing with the SEC under CIK 1017645.
AI Fund Analysis
StableSector Allocation
AUM History
Top Equity Holdings by Value
Quarterly Activity — Q1 2026
Click any card to unlockTop Holdings
- —
Quality
$605.1M46,656,695 sh - 44.8#1,753
Quality
$398.2M21,259,683 sh - —
Quality
$391.6M20,566,133 sh - 46.1
Quality
$240.3M15,337,495 sh - —
Quality
$226.9M8,031,252 sh - —
Quality
$75.8M13,110,492 sh - —
Quality
$68.8M707,791 sh - 13.2
Quality
$63.6M4,101,865 sh - —
Quality
$53.8M1,354,830 sh - —
Quality
$20.9M5,324,998 sh
| Company | Quality | Value | Shares |
|---|---|---|---|
 dLocal Ltd$DLO | — | $605.1M | 46,656,695 |
 Chime Financial, Inc.$CHYM | 44.8#1,753 | $398.2M | 21,259,683 |
 XP Inc.$XP | — | $391.6M | 20,566,133 |
 ALKAMI TECHNOLOGY, INC.$ALKT | 46.1 | $240.3M | 15,337,495 |
 Pharvaris N.V.$PHVS | — | $226.9M | 8,031,252 |
 European Wax Center, Inc.$EWCZ | — | $75.8M | 13,110,492 |
 Revolution Medicines, Inc.$RVMD | — | $68.8M | 707,791 |
 Nurix Therapeutics, Inc.$NRIX | 13.2 | $63.6M | 4,101,865 |
 Centessa Pharmaceuticals plc$CNTA | — | $53.8M | 1,354,830 |
 RISKIFIED LTD.$RSKD | — | $20.9M | 5,324,998 |
Unlock AI quality scores for every holding
32-signal composite ranking on each of GENERAL ATLANTIC, L.P.'s 12 positions.
Showing top 10 of 12 holdings.
Sector Allocation
Financials
$790.0M
Industrials
$626.0M
Healthcare
$413.1M
Technology
$240.3M
Consumer Discretionary
$78.9M
Full Holdings — GENERAL ATLANTIC, L.P. (Q1 2026)
All 12 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.
| # | Ticker | Company | Value | Weight | QoQ | Quality |
|---|---|---|---|---|---|---|
| 1 | $DLO | dLocal Ltd | $605.1M | 28.2% | +0% | — |
| 2 | $CHYM | Chime Financial, Inc. | $398.2M | 18.5% | +0% | 44.8 |
| 3 | $XP | XP Inc. | $391.6M | 18.2% | -9% | — |
| 4 | $ALKT | ALKAMI TECHNOLOGY, INC. | $240.3M | 11.2% | +28% | 46.1 |
| 5 | $PHVS | Pharvaris N.V. | $226.9M | 10.6% | +0% | — |
| 6 | $EWCZ | European Wax Center, Inc. | $75.8M | 3.5% | +0% | — |
| 7 | $RVMD | Revolution Medicines, Inc. | $68.8M | 3.2% | -75% | — |
| 8 | $NRIX | Nurix Therapeutics, Inc. | $63.6M | 3.0% | -16% | 13.2 |
| 9 | $CNTA | Centessa Pharmaceuticals plc | $53.8M | 2.5% | -78% | — |
| 10 | $RSKD | RISKIFIED LTD. | $20.9M | 1.0% | +0% | — |
| 11 |  $GROV | Grove Collaborative Holdings, Inc. | $3.2M | 0.1% | +0% | 21.9 |
| 12 |  $BULL | Webull Corp | $243,917 | 0.0% | +0% | — |
Exited Positions (1)
$ALHC Alignment Healthcare, Inc.Browse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
Available Analysis
13F Pro tracks comprehensive institutional data for GENERAL ATLANTIC, L.P. including:
Track GENERAL ATLANTIC, L.P.'s Full Portfolio
See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for GENERAL ATLANTIC, L.P. and 8,700+ other institutional investors.
Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).
AI-Powered Hedge Fund Analysis: GENERAL ATLANTIC, L.P.
13F Pro is an AI hedge fund tracker and stock research platform. For GENERAL ATLANTIC, L.P. (SEC CIK: 1017645), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in GENERAL ATLANTIC, L.P.'s portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.